These outcomes, together with a past report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-rel